跳至主要内容
临床试验/ISRCTN31118803
ISRCTN31118803已完成未知

The Glucose Insulin in Stroke Trial (GIST)

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 2,500 人开始时间: 2004年1月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,500

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

入选标准

  • All acute stroke patients (less than 24 hours onset) with cerebral infarction (CI) or primary intracerebral haemorrhage (PICH) and admission plasma glucose greater than 6.1 and less than 17 mMol/l.

排除标准

  • 1. Subarachnoid haemorrhage
  • 2. Renal failure (urea 320 mMol/l or creatinine 3200 mMol/l)
  • 3. Anaemia (Hb less than 9.0 g/dl)
  • 5. Isolated posterior circulation syndromes with no physical disability
  • 6. Pure language disorders
  • 7. Established history of insulin dependent diabetes mellitus
  • 8. Previous disabling stroke (Modified Rankin score 3)
  • 9. Established diagnosis of dementia or abbreviated mental test score less than 7/10
  • 10. Symptomatic cardiac failure - New York Heart Association (NYHA) Grade 3 or 4

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

相似试验

The Glucose Insulin in Stroke Trial (GIST) | 临床试验